Skip to main content

Articles

Page 1 of 9

  1. Accurately identifying the factors contributing to decline in activities of daily living (ADL) is important for preventing such decline in patients undergoing hemodialysis (HD). We studied the prevalence and n...

    Authors: Yusuke Matsunaga, Hiroki Takahashi, Yuta Suzuki, Shohei Yamamoto, Keigo Imamura, Shun Yoshikoshi, Juri Uchida, Takuya Nakajima, Narumi Fukuzaki, Manae Harada, Ryota Matsuzawa, Atsushi Yoshida, Kanako Ichikura, Yuko Fukase, Norio Murayama, Hanako Murase…
    Citation: Renal Replacement Therapy 2022 8:36
  2. Person-centered care (PCC) is considered an important component of high-quality care in hemodialysis units. Hemodialysis patients and nurses may have different perceptions of person-centeredness in hemodialysi...

    Authors: Simin Abdolsattari, Mansour Ghafourifard and Kobra Parvan
    Citation: Renal Replacement Therapy 2022 8:35
  3. To prevent tunnel infection of indwelling catheters, impregnation with antiseptics or antibiotics is effective. However, 13 patients using chlorhexidine–silver sulfadiazine-impregnated catheters experienced se...

    Authors: Koji Umeda, Masaji Tachikawa, Yoshinao Azuma and Tsutomu Furuzono
    Citation: Renal Replacement Therapy 2022 8:34
  4. Reportedly, dialysis solutions containing molecular hydrogen (H2) might ameliorate patient-reported fatigue in hemodialysis (HD) patients. However, it is unknown whether its impact might differ with different ...

    Authors: Susumu Uemura, Yoshitaka Kegasa, Keigo Tada, Taichi Tsukahara, Shigeru Kabayama, Tae Yamamoto, Mariko Miyazaki, Joji Takada and Masaaki Nakayama
    Citation: Renal Replacement Therapy 2022 8:32
  5. Biomarkers are needed to diagnose kidney rejection in transplant recipients. We evaluated whether dipeptidyl peptidase-4 (DPP-4) could serve as a biomarker of rejection.

    Authors: Atsushi Yamagishi, Hayato Nishida, Hiromi Ito, Hiroki Fukuhara and Norihiko Tsuchiya
    Citation: Renal Replacement Therapy 2022 8:31
  6. To assess the association between the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with all-cause mortality in Peruvian patients with chronic kidney disease (CKD) attending a ter...

    Authors: Gianfranco Eddú Umeres-Francia, María Valentina Rojas-Fernández, Percy Herrera-Añazco and Vicente Aleixandre Benites-Zapata
    Citation: Renal Replacement Therapy 2022 8:30
  7. Fungal peritonitis is a common and serious complication associated with peritoneal dialysis (PD), and it is often refractory to treatment.

    Authors: Satoshi Nishioka, Masahito Yamanaka, Yasushi Kunisho, Yuhei Aoki, Masato Higasitani, Tomoko Yokoyama, Tomoyo Oyama, Misako Ohkusu, Katuhiko Kamei and Tadashi Sofue
    Citation: Renal Replacement Therapy 2022 8:29
  8. Intravenous administration of amino acid (AA) formulation (IVAA) as intradialytic parenteral nutrition is widely used for malnourished patients with end-stage kidney disease (ESKD) treated with hemodialysis (H...

    Authors: Masako Fujiwara, Itiro Ando, You Shishido, Yutaka Imai and Hiroyuki Terawaki
    Citation: Renal Replacement Therapy 2022 8:28
  9. Dulaglutide is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of type 2 diabetes mellitus (T2DM). However, the efficacy and safety of dulaglutide remain unclear in in...

    Authors: Daisuke Ugamura, Michihiro Hosojima, Hideyuki Kabasawa, Naohito Tanabe, Yuta Yoshizawa, Yoshiki Suzuki, Akihiko Saito and Ichiei Narita
    Citation: Renal Replacement Therapy 2022 8:26
  10. Global warming may reduce food production and force people to adopt dietary habits of inadequate quantity or quality. Such dietary habits could trigger chronic kidney disease through inappropriate nutrition or...

    Authors: Kei Nagai, Shiho Kosaka, Yuka Kawate and Norihiro Itsubo
    Citation: Renal Replacement Therapy 2022 8:25
  11. Since 2012, Senegal has conducted a national program to cover renal therapy (dialysis) expenses in public hospitals and social security-approved centers. Given the increasing demand for dialysis, national guid...

    Authors: Fatoumata Mbagnick Faye and Martine Audibert
    Citation: Renal Replacement Therapy 2022 8:24
  12. Obturator hernia (OH) is an extremely rare abdominal wall hernia with risk factors including aging, female sex, emaciation, and increased abdominal pressure. Its symptoms are nonspecific, and diagnosis is ofte...

    Authors: Kosei Yamaguchi, Mineaki Kitamura, Junichiroh Hashiguchi, Takashi Harada, Satoshi Funakoshi, Susumu Eguchi, Hiroshi Mukae and Tomoya Nishino
    Citation: Renal Replacement Therapy 2022 8:23
  13. We experienced that some hemodialysis (HD) patients with coronavirus disease 2019 (COVID-19) exacerbated hypoxemia during HD. Though HD-induced hypoxemia has been reported, there have been no reports of HD-ind...

    Authors: Masataro Toda, Ayumi Yoshifuji, Kentaro Fujii, Motoaki Komatsu, Ai Kato, Ikue Tamura, Wataru Sugi and Munekazu Ryuzaki
    Citation: Renal Replacement Therapy 2022 8:22
  14. Identification of the pathogenesis of peritoneal dialysis (PD)-related peritonitis is important. However, identification of endogenous peritonitis, especially hematogenous infection, is difficult, and there ar...

    Authors: Kento Fukumitsu, Hideaki Oka, Takaki Iwamoto, Mika Kondo, Yutaro Hirashima, Taro Kamimura, Toshiaki Nakano and Takanari Kitazono
    Citation: Renal Replacement Therapy 2022 8:21
  15. Hypokalemia is common in patients with malnutrition undergoing hemodialysis and is often involved in the development of lethal arrhythmia. Moreover, hemodialysis therapy decreases the serum potassium concentra...

    Authors: Takayuki Uchida, Susumu Ookawara, Kiyonori Ito, Hitomi Okada, Hideyuki Hayasaka, Masaya Kofuji, Masahiko Kimura, Yuichiro Ueda, Tadashi Hasebe, Naoki Momose and Yoshiyuki Morishita
    Citation: Renal Replacement Therapy 2022 8:20
  16. Although recently strengthened immunosuppression protocols have decreased the incidence of clinical acute rejection of renal transplants, subclinical acute rejection and borderline changes remain problematic. ...

    Authors: Kei Sakurabayashi, Masaki Muramatsu, Yoshihiro Itabashi, Hideyo Oguchi, Takeshi Kawamura, Yuko Hamasaki, Tetsuo Mikami, Naobumi Tochigi, Seiichiro Shishido and Ken Sakai
    Citation: Renal Replacement Therapy 2022 8:19
  17. Patients with coronavirus disease 2019 (COVID-19) who receive dialysis therapy develop more severe disease and have a poorer prognosis than patients who do not. Although various data on the treatment of patien...

    Authors: Ayumi Yoshifuji, Munekazu Ryuzaki, Yuki Uehara, Norio Ohmagari, Toru Kawai, Yoshihiko Kanno, Kan Kikuchi, Hiroshi Kon, Ken Sakai, Toshio Shinoda, Yaoko Takano, Junko Tanaka, Kazuhiko Hora, Yasushi Nakazawa, Naoki Hasegawa, Norio Hanafusa…
    Citation: Renal Replacement Therapy 2022 8:18
  18. Acute pericarditis causes acute inflammation of the pericardium. Although most cases of pericarditis are idiopathic with no identifiable cause, its etiology can be infectious, such as viral, bacterial, mycotic...

    Authors: Masahiro Egawa, Shungo Fujii, Kentaro Takase, Ryuichi Yoshimura, Asuka Yamauchi, Kaori Yoshikane, Kazuaki Tanabe, Hiroaki Shiina and Takafumi Ito
    Citation: Renal Replacement Therapy 2022 8:17
  19. Management of presenteeism in the context of chronic kidney disease (CKD) is essential for disease management, ensuring the workforce’s availability, and reducing health-related costs. The purpose of this case...

    Authors: Aki Tabata, Hiroki Yabe, Takehide Katogi, Tomoya Yamaguchi, Yuya Mitake, Tomohiro Shirai and Takayuki Fujii
    Citation: Renal Replacement Therapy 2022 8:16
  20. Although atypical hemolytic uremic syndrome (aHUS) is a life-threatening clinical entity that was characterized by thrombotic microangiopathy (TMA) with the activation of the complement system and the efficien...

    Authors: Noriaki Kawano, Tomohiro Abe, Naoko Ikeda, Yuri Nagahiro, Sayaka Kawano, Taro Tochigi, Takashi Nakaike, Kiyoshi Yamashita, Keisuke Kubo, Atsushi Yamanaka, Sohshi Terasaka, Kousuke Marutsuka, Koichi Mashiba, Ikuo Kikuchi, Kazuya Shimoda, Masanori Matsumoto…
    Citation: Renal Replacement Therapy 2022 8:15
  21. The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal kidney function. As of August 2021, only remdesivir has been app...

    Authors: Jun Ito, Moritsugu Kimura, Tomoyuki Toya, Konomi Isozumi, Atsuro Kawaji, Yudai Isozaki and Masafumi Fukagawa
    Citation: Renal Replacement Therapy 2022 8:14
  22. Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of a COVID-19 vaccine. This study aimed to investiga...

    Authors: Masatoshi Matsunami, Tomo Suzuki, Junko Fukuda, Toshiki Terao, Kohei Ukai, Shinnosuke Sugihara, Takumi Toishi, Kanako Nagaoka, Mayumi Nakata, Mamiko Ohara, Jun Yashima, Hiroshi Kuji and Kosei Matsue
    Citation: Renal Replacement Therapy 2022 8:13
  23. In a previous study, patients who underwent unplanned hemodialysis initiation did not have improved nutritional status and activities of daily living (ADL) at discharge compared with patients whose initiation ...

    Authors: Tomoko Yoshida, Togo Aoyama, Yuko Morioka and Yasuo Takeuchi
    Citation: Renal Replacement Therapy 2022 8:12
  24. We previously reported the nutritional advantage of polymethylmethacrylate (PMMA) membranes to prevent the progression of malnutrition in dialysis patients. In this study, we examined whether a new PMMA dialyz...

    Authors: Tetsuro Chida, Hiroyuki Igarashi and Ikuto Masakane
    Citation: Renal Replacement Therapy 2022 8:11
  25. The clinical significance of de novo donor-specific antigen (DSA) in renal transplant recipients is not yet fully understood. This study aimed to report the prevalence of de novo DSA detected in antihuman leuk...

    Authors: Kenji Nakamura, Atsuro Sawada, Yuki Kita, Jin Kono, Kimihiko Masui, Takuma Sato, Takeshi Sano, Takayuki Goto, Shusuke Akamatsu, Osamu Ogawa and Takashi Kobayashi
    Citation: Renal Replacement Therapy 2022 8:10
  26. Since 2015, the Committee of International Communication for Academic Research of the Japanese Society for Dialysis Therapy has held a symposium every year at the society’s Annual Congress to discuss the curre...

    Authors: Toru Hyodo, Nobuhito Hirawa, Yoshitaka Isaka, Hidetomo Nakamoto, Pichthida Thim, Elin Phon, Chanseila Hy, Sovandy Chan, Kenichi Kokubo, Hirokazu Matsubara, Haruki Wakai, Akihiro C. Yamashita and Hideki Kawanishi
    Citation: Renal Replacement Therapy 2022 8:9
  27. Patients on hemodialysis (HD) face a high mortality risk from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and they are therefore prioritized for...

    Authors: Mineaki Kitamura, Takahiro Takazono, Kazuko Yamamoto, Takashi Harada, Satoshi Funakoshi, Hiroshi Mukae and Tomoya Nishino
    Citation: Renal Replacement Therapy 2022 8:8
  28. Renal replacement therapy (RRT) is used to manage critically ill patients with severe acute kidney injury (AKI-D), and it is undoubtedly life-sustaining for most patients. However, the prolonged unnecessary us...

    Authors: Helmut Schiffl
    Citation: Renal Replacement Therapy 2022 8:7
  29. Oral disease may be increased in people with end-stage renal disease and associated with inflammation, cardiovascular disease, and mortality. Moreover, oral disease may be essential to decide the prognosis of ...

    Authors: Takeyuki Hiramatsu, Shota Okumura, Daiki Iguchi and Hiroshi Kojima
    Citation: Renal Replacement Therapy 2022 8:6
  30. Aortic arch calcification (AAC) is a well-known risk factor for death in patients on hemodialysis (HD); however, the causes of death among them have not been well studied. The study aimed to investigate the di...

    Authors: Toyohiro Hashiba, Mototsugu Tanaka, Tomoko Honda, Satoru Kishi, Yoshiyasu Ogura, Yuto Takenaka, Satoshi Furuse, Kyosuke Nishio, Kazunobu Masaki, Tatsuya Kano and Naobumi Mise
    Citation: Renal Replacement Therapy 2022 8:5
  31. Assisted peritoneal dialysis (asPD) is a modality intended for not self-sufficient patients, mainly elderly, who are not able to perform peritoneal dialysis (PD) alone and require some help to manage the treat...

    Authors: Anna Giuliani, Luca Sgarabotto, Sabrina Milan Manani, Ilaria Tantillo, Claudio Ronco and Monica Zanella
    Citation: Renal Replacement Therapy 2022 8:2
  32. Hemodialysis (HD) is a protein catabolic event. However, the amino acid (AA) kinetics during HD sessions involved in protein breakdown have not been well investigated in patients with and without diabetes mell...

    Authors: Masako Fujiwara, Itiro Ando, You Shishido, Yutaka Imai and Hiroyuki Terawaki
    Citation: Renal Replacement Therapy 2022 8:1
  33. All-cause mortality can be reduced in patients receiving European-style high-volume post-dilution online hemodiafiltration (post-OHDF) compared with hemodialysis (HD). Japanese-style high-volume pre-dilution o...

    Authors: Kazuyoshi Okada, Hiroyuki Michiwaki, Manabu Tashiro, Tomoko Inoue, Hisato Shima, Jun Minakuchi and Shu Kawashima
    Citation: Renal Replacement Therapy 2021 7:70
  34. End-of-life medical care for patients receiving maintenance hemodialysis (HD) therapy has become an increasingly important issue worldwide. Thus far, no clear indicators and/or biomarkers exist regarding the t...

    Authors: Tadashi Yoshida, Kohkichi Morimoto, Takashin Nakayama, Takuto Torimitsu, Shotaro Kosugi, Takuma Oshida, Nobuko Yamaguchi and Mototsugu Oya
    Citation: Renal Replacement Therapy 2021 7:69
  35. Although not indicated in the USA, edoxaban tosylate hydrate 15 mg is used for venous thromboembolism (VTE) prophylaxis after orthopedic surgery of the lower extremities in Japan. However, its efficacy and saf...

    Authors: Teruhisa Kinoshita, Sayuri Otsuka, Shota Torii, Yoko Tsugeno, Shiori Fukaya, Mari Sobue, Ayumi Ishihara, Takashi Sakakibara and Norio Takimoto
    Citation: Renal Replacement Therapy 2021 7:68
  36. Peripheral artery disease (PAD) is a serious complication in hemodialysis (HD) patients. Low skin perfusion pressure (SPP) is a useful marker for detecting PAD. Malnutrition is an important cause of intractabl...

    Authors: Maho Watanabe, Asami Fuji, Sayuri Tokushima, Keiko Uemoto, Masayo Ueno, Yuko Shimomura, Kenji Ito, Tetsuhiko Yasuno, Kosuke Masutani and Takao Saito
    Citation: Renal Replacement Therapy 2021 7:67
  37. Hyperkalemia is a serious medical condition that requires immediate intervention. However, pseudohyperkalemia and reverse pseudohyperkalemia are misleading clinical manifestations that can result in incorrect ...

    Authors: Muneera Alabdulqader, Hanaa Al Alawyat, Mohammed F. Kasem, Abdelfattah Ibrahim and Abdelwahab Omara
    Citation: Renal Replacement Therapy 2021 7:66
  38. The prevalence of end-stage renal disease (ESRD) is on the rise worldwide. Meanwhile, the number of older people requiring dialysis therapy is increasing as a result of this population. We found that starting ...

    Authors: Atthaphong Phongphithakchai, Phongsak Dandecha, Sukit Raksasuk and Thatsaphan Srithongkul
    Citation: Renal Replacement Therapy 2021 7:65
  39. Peritoneal dialysis (PD)-associated peritonitis caused by Sphingomonas paucimobilis (S. paucimobilis) is very rare, and most of the characteristics of such cases are still unknown.

    Authors: Chiharu Kinoshita, Koichi Matsuda, Yumiko Kawai, Takayuki Hagiwara and Akane Okada
    Citation: Renal Replacement Therapy 2021 7:64
  40. Hemodialysis (HD) patients are at a high risk of falls and fractures. The amount of physical activity (PA) they perform may be limited by psychosomatic factors associated with fear of falling, leading to frail...

    Authors: Nobuyuki Shirai, Suguru Yamamoto, Yutaka Osawa, Atsuhiro Tsubaki, Shinichiro Morishita, Sumiyo Nitami and Ichiei Narita
    Citation: Renal Replacement Therapy 2021 7:63
  41. Hemodialysis is a medical technology implemented for various renal diseases and has a significant budget impact in Japan. Hemodialysis also affects health-related quality of life, as it interferes with daily l...

    Authors: Shinichi Noto, Masashi Miyazaki, Hidemi Takeuchi and Shinya Saito
    Citation: Renal Replacement Therapy 2021 7:62
  42. The appropriate dosing of imipenem for critically ill AKI patients undergoing CRRT remains scarce.

    Authors: Dhakrit Rungkitwattanakul, Taniya Charoensareerat, Pathakorn Kerdnimith, Nutsinee Kosumwisaisakul, Piyakamol Teeranaew, Apinya Boonpeng, Sutthiporn Pattharachayakul, Nattachai Srisawat and Weerachai Chaijamorn
    Citation: Renal Replacement Therapy 2021 7:61
  43. Removal of anti-blood group antibodies is important for successful ABO-incompatible kidney transplantation (ABOi-KTx). Double-filtration plasmapheresis (DFPP) using albumin solution removes antibodies effectiv...

    Authors: Daiki Iwami, Takenao Matsumoto, Kota Ono, Kiyohiko Hotta, Minoru Ota, Yuki Chiba, Hajime Sasaki, Takayuki Hirose, Haruka Higuchi, Yusuke Takada, Naoya Iwahara, Sachiyo Murai and Nobuo Shinohara
    Citation: Renal Replacement Therapy 2021 7:60
  44. The Japanese Association of Dialysis Physicians, the Japanese Society for Dialysis Therapy, and the Japanese Society of Nephrology jointly established COVID-19 Task Force Committee and began surveying the numb...

    Authors: Kan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, Tomoyuki Yamakawa, Oota Yoshihiro, Norio Hanafusa, Ken Sakai, Yoshihiko Kanno, Ryoichi Ando, Toshio Shinoda, Hidetomo Nakamoto and Tadao Akizawa
    Citation: Renal Replacement Therapy 2021 7:59
  45. Enhanced oxidative stress is involved with fatigue in hemodialysis (HD) patients. Molecular hydrogen (H2) could improve the redox status. Thus, the study examines whether HD solution rendered by electrolyzed wate...

    Authors: Yoshihiro Tsujimoto, Daisuke Kuratsune, Shigeru Kabayama, Mariko Miyazaki, Yasuyoshi Watanabe, Yoshiki Nishizawa and Masaaki Nakayama
    Citation: Renal Replacement Therapy 2021 7:58
  46. Though treatment of anemia in chronic kidney disease (CKD) patients has been improved remarkably by erythropoiesis-stimulating agents (ESA), hypo-responsiveness to ESA poses a persistent problem in a subgroup ...

    Authors: Akira Ishimitsu, Hiroshi Satonaka, Masahito Furuichi, Yoshiki Murayama, Akihiro Tojo and Toshihiko Ishimitsu
    Citation: Renal Replacement Therapy 2021 7:57

Annual Journal Metrics

  • Speed
    31 days to first decision for all manuscripts (Median)
    127 days to first decision for reviewed manuscripts only (Median)

    Usage 
    362,348 Downloads (2021)
    57 Altmetric mentions (2021)